{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:49:28Z","timestamp":1790887768961,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173862"],"award-info":[{"award-number":["82173862"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009331","name":"Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support","doi-asserted-by":"crossref","award":["ZYLX202123"],"award-info":[{"award-number":["ZYLX202123"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12813-w","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:08:56Z","timestamp":1770894536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The pharmacokinetics (PK) \/ pharmacodynamics (PD) of pretomanid, delamanid and bedaquiline in the BALB\/c mouse model of central nervous system tuberculosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Hui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangxue","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"12813_CR1","unstructured":"WHO. Global tuberculosis report 2024 https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024."},{"issue":"7","key":"12813_CR2","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1007\/s00415-022-11052-8","volume":"269","author":"A Navarro-Flores","year":"2022","unstructured":"Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, et al. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta\u2013analysis. J Neurol. 2022;269(7):3482\u201394. https:\/\/doi.org\/10.1007\/s00415-022-11052-8.","journal-title":"J Neurol"},{"key":"12813_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.12688\/wellcomeopenres.15506.3","volume":"4","author":"FV Cresswell","year":"2021","unstructured":"Cresswell FV, Davis AG, Sharma K, et al. Recent developments in tuberculous meningitis pathogenesis and diagnostics. Wellcome Open Res. 2021;4:164.","journal-title":"Wellcome Open Res"},{"issue":"1","key":"12813_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13760-020-01575-0","volume":"121","author":"A Cherian","year":"2021","unstructured":"Cherian A, Ajitha KC, Iype T, et al. Neurotuberculosis: an update. Acta Neurol Belg. 2021;121(1):11\u201321.","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"12813_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ddr.21498","volume":"80","author":"Y Li","year":"2019","unstructured":"Li Y, Sun F, Zhang W. Bedaquiline and Delamanid in the treatment of multidrug-resistant tuberculosis: promising but challenging. Drug Dev Res. 2019;80(1):98\u2013105.","journal-title":"Drug Dev Res"},{"key":"12813_CR6","doi-asserted-by":"publisher","first-page":"e00913","DOI":"10.1128\/AAC.00913-19","volume":"63","author":"EW 6 Tucker","year":"2019","unstructured":"6 Tucker EW, Pieterse L, Zimmerman MD, et al. Delamanid central nervous system pharmacokinetics in tuberculous meningitis in rabbits and humans. Antimicrob Agents Chemother. 2019;63:e00913\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"12813_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/00498254.2015.1067935","volume":"46","author":"A Shobo","year":"2016","unstructured":"Shobo A, Bratkowska D, Baijnath S, et al. Tissue distribution of pretomanid in rat brain via mass spectrometry imaging. Xenobiotica. 2016;46:247\u201352.","journal-title":"Xenobiotica"},{"issue":"12","key":"12813_CR8","doi-asserted-by":"publisher","first-page":"e245612","DOI":"10.1136\/bcr-2021-245612","volume":"14","author":"P Howell","year":"2021","unstructured":"Howell P, Upton C, Mvuna N, et al. Sterile tuberculous granuloma in a patient with XDR-TB treated with bedaquiline, pretomanid and linezolid. BMJ Case Rep. 2021;14(12):e245612. https:\/\/doi.org\/10.1136\/bcr-2021-245612.","journal-title":"BMJ Case Rep"},{"key":"12813_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/cid\/civ921","volume":"62","author":"OW Akkerman","year":"2016","unstructured":"Akkerman OW, Odish OF, Bolhuis MS, et al. Pharmacokinetics of bedaquiline in cerebrospinal fluid and serum in multidrug-resistant tuberculous meningitis. Clin Infect Dis. 2016;62:523\u20134.","journal-title":"Clin Infect Dis"},{"key":"12813_CR10","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/jac\/dkac067","volume":"77","author":"CM Upton","year":"2022","unstructured":"Upton CM, Steele CI, Maartens G, et al. Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB). J Antimicrob Chemother. 2022;77:1720\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"12813_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jchromb.2015.10.039","volume":"1006","author":"L Wang","year":"2015","unstructured":"Wang L, Ma Y, Duan H, et al. Pharmacokinetics and tissue distribution study of PA-824 in rats by LC-MS\/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1006:194\u2013200. https:\/\/doi.org\/10.1016\/j.jchromb.2015.10.039.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"12813_CR12","doi-asserted-by":"publisher","first-page":"7974","DOI":"10.1038\/s41467-022-35730-3","volume":"13","author":"F Mota","year":"2022","unstructured":"Mota F, Ruiz-Bedoya CA, Tucker EW, et al. Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies. Nat Commun. 2022;13(1):7974. https:\/\/doi.org\/10.1038\/s41467-022-35730-3.","journal-title":"Nat Commun"},{"issue":"6","key":"12813_CR13","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1128\/AAC.49.6.2294-2301.2005","volume":"49","author":"AJ Lenaerts","year":"2005","unstructured":"Lenaerts AJ, Gruppo V, Marietta KS, et al. Preclinical testing of the Nitroimidazopyran PA824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models. Antimicrob Agents Chemother. 2005;49(6):2294\u2013301.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"12813_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000528274","volume":"102","author":"JM Aguilar Diaz","year":"2023","unstructured":"Aguilar Diaz JM, Abulfathi AA, Te Brake LH, et al. New and repurposed drugs for the treatment of active tuberculosis: an update for clinicians. Respiration. 2023;102(2):83\u2013100. https:\/\/doi.org\/10.1159\/000528274.","journal-title":"Respiration"},{"issue":"4","key":"12813_CR15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/cid\/ciab992","volume":"75","author":"RR Kempker","year":"2022","unstructured":"Kempker RR, Smith AGC, Avaliani T, et al. Cycloserine and linezolid for tuberculosis meningitis: Pharmacokinetic evidence of potential usefulness. Clin Infect Dis. 2022;75(4):682\u20139. https:\/\/doi.org\/10.1093\/cid\/ciab992.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"12813_CR16","doi-asserted-by":"publisher","first-page":"e02164","DOI":"10.1128\/AAC.02164-20","volume":"65","author":"H Zhu","year":"2021","unstructured":"Zhu H, Fu L, Wang B, et al. Activity of Clofazimine and TBI-166 against Mycobacterium tuberculosis in different administration intervals in mouse tuberculosis models. Antimicrob Agents Chemother. 2021;65(4):e02164\u201320. https:\/\/doi.org\/10.1128\/AAC.02164-20.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"12813_CR17","doi-asserted-by":"publisher","first-page":"e0065822","DOI":"10.1128\/aac.00658-22","volume":"66","author":"YM Ding","year":"2022","unstructured":"Ding YM, Zhu H, Fu L, et al. Superior efficacy of a TBI-166, Bedaquiline, and Pyrazinamide combination regimen in a murine model of tuberculosis. Antimicrob Agents Chemother. 2022;66(9):e0065822. https:\/\/doi.org\/10.1128\/aac.00658-22.","journal-title":"Antimicrob Agents Chemother"},{"key":"12813_CR18","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1128\/AAC.05293-11","volume":"55","author":"R Tasneen","year":"2011","unstructured":"Tasneen R, et al. Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis. Antimicrob Agents Chemother. 2011;55:5485\u201392.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"12813_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1474-4422(21)00435-X","volume":"21","author":"J Huynh","year":"2022","unstructured":"Huynh J, Donovan J, Phu NH, et al. Tuberculous meningitis: progress and remaining questions. Lancet Neurol. 2022;21(5):450\u201364. https:\/\/doi.org\/10.1016\/S1474-4422(21)00435-X.","journal-title":"Lancet Neurol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12813-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12813-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12813-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:44:39Z","timestamp":1774284279000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12813-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12813"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12813-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by Animal Ethics Committee of the Beijing Chest Hospital-Affiliate of Capital Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"610"}}